Armoiry, X., Spath, H., Clarke, A., Connock, M., Sutcliffe, P., & Dussart, C. (2019). Comparison of health technology assessment for new medicines in France and England: An example based on ixazomib for patients with relapsed or refractory multiple myeloma. Taylor & Francis Group.
Citação norma ChicagoArmoiry, Xavier, Hans-Martin Spath, Aileen Clarke, Martin Connock, Paul Sutcliffe, and Claude Dussart. Comparison of Health Technology Assessment for New Medicines in France and England: An Example Based On Ixazomib for Patients With Relapsed or Refractory Multiple Myeloma. Taylor & Francis Group, 2019.
Citação norma MLAArmoiry, Xavier, et al. Comparison of Health Technology Assessment for New Medicines in France and England: An Example Based On Ixazomib for Patients With Relapsed or Refractory Multiple Myeloma. Taylor & Francis Group, 2019.